Condensed Consolidated Statement of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (63,344)	$ (53,088)
Net unrealized loss on marketable securities	(149)	0
Comprehensive loss	(63,493)	(53,088)
Comprehensive loss attributable to non-controlling interest	(32,832)	(44,757)
Comprehensive loss attributable to Rani Therapeutics Holdings, Inc.	$ (30,661)	$ (8,331)